ARS Pharmaceuticals, Inc.

CHARLES SCHWAB INVESTMENT MANAGEMENT INC SPRY

Report date

12/31/2025

Quarter

2025 Q4

Filed

2/13/2026

Shares

550,932

Value ($000)

6,418

Weight

0.0%

2021 Q1 - 2025 Q4 (19 filings)

Shares History

History scope: non-option holdings only (PUT/CALL rows excluded).

All 13F Holders	Filing date	Value ($000s)	% of Holdings	Shares	Reporting period
2025 Q4	2/13/2026	6,418	0.0%	550,932	12/31/2025
2025 Q3	11/10/2025	5,234	0.0%	520,758	9/30/2025
2025 Q2	8/12/2025	7,716	0.0%	442,202	6/30/2025
2025 Q1	9/15/2025	5,242	0.0%	416,657	3/31/2025
2024 Q4	2/6/2025	4,510	0.0%	427,477	12/31/2024
2024 Q3	11/12/2024	6,147	0.0%	423,947	9/30/2024
2024 Q2	8/12/2024	3,536	0.0%	415,530	6/30/2024
2024 Q1	5/9/2024	3,529	0.0%	345,295	3/31/2024
2023 Q4	2/6/2024	1,806	0.0%	329,550	12/31/2023
2023 Q3	11/8/2023	1,226	0.0%	324,403	9/30/2023
2023 Q2	8/10/2023	480	0.0%	71,611	6/30/2023
2023 Q1	5/12/2023	105	0.0%	16,170	3/31/2023
2022 Q4	2/13/2023	138	0.0%	16,170	12/31/2022
2022 Q2	8/15/2022	452	0.0%	106,414	6/30/2022
2022 Q1	5/13/2022	518	0.0%	147,375	3/31/2022
2021 Q4	2/11/2022	992	0.0%	148,943	12/31/2021
2021 Q3	11/16/2021	1,389	0.0%	139,105	9/30/2021
2021 Q2	8/16/2021	2,651	0.0%	85,804	6/30/2021
2021 Q1	5/17/2021	3,683	0.0%	84,413	3/31/2021